arrow
R

Rainer Strotmann

merck kga a
H指数:14
被引数:2,465

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors

ATR抑制剂Tuvusertib对实体瘤患者QTc间期影响的综合非临床与临床风险评估

2026-02-100
OAAI
Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib

整合群体药代动力学、药效动力学和安全性的综合分析,以指导ATR抑制剂Tuvusertib在临床开发中的剂量选择

2025-08-210
OAAI
V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis

V2加压素受体缺陷导致参与电解质和水稳态的肾脏和下丘脑成分的表达和功能变化

2008-10-0118
PREAI